Litcius/Paper detail

The nanobody targeting PD-L1 and CXCR4 counteracts pancreatic stellate cell-mediated tumour progression by disrupting tumour microenvironment

Yaxian Li, Yuejiang Zheng, Shuyi Xu, H. H. Hu, Liyun Peng, Jianwei Zhu, Mingyuan Wu

2024International Immunopharmacology12 citationsDOI

Topics & Concepts

Pancreatic cancerTumor microenvironmentCancer researchStromal cellHepatic stellate cellImmune systemPI3K/AKT/mTOR pathwayEpithelial–mesenchymal transitionCXCR4MetastasisChemistryBiologySignal transductionMedicineCancerImmunologyPathologyCell biologyChemokineInternal medicineTumor cellsPancreatic and Hepatic Oncology ResearchCancer Cells and MetastasisCancer Immunotherapy and Biomarkers
The nanobody targeting PD-L1 and CXCR4 counteracts pancreatic stellate cell-mediated tumour progression by disrupting tumour microenvironment | Litcius